Moderna Inc/ US60770K1079 /
2024-06-03 7:40:46 PM | Chg. +4.1200 | Volume | Bid2024-06-03 | Ask2024-06-03 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
146.6700USD | +2.89% | 3.31 mill. Turnover: 327.43 mill. |
146.4400Bid Size: 300 | 146.6800Ask Size: 400 | 56.16 bill.USD | - | - |
GlobeNewswire
05-22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
05-12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
05-08
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
05-02
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-01
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
05-01
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04-04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...